Amyloid Against Amyloid: Dimeric Amyloid Fragment Ameliorates Cognitive Impairments by Direct Clearance of Oligomers and Plaques
-
- Hee Yang Lee
- Department of Pharmacy and Yonsei Institute of Pharmaceutical Sciences Yonsei University Yeonsu-gu Incheon 21983 South Korea
-
- Seungyeop Baek
- Department of Pharmacy and Yonsei Institute of Pharmaceutical Sciences Yonsei University Yeonsu-gu Incheon 21983 South Korea
-
- Minhae Cha
- Department of Pharmacy and Yonsei Institute of Pharmaceutical Sciences Yonsei University Yeonsu-gu Incheon 21983 South Korea
-
- Seung‐Hoon Yang
- Department of Medical Biotechnology Dongguk University Jung-gu Seoul 04620 South Korea
-
- Illhwan Cho
- Department of Pharmacy and Yonsei Institute of Pharmaceutical Sciences Yonsei University Yeonsu-gu Incheon 21983 South Korea
-
- Heewon Shin
- Department of Pharmacy and Yonsei Institute of Pharmaceutical Sciences Yonsei University Yeonsu-gu Incheon 21983 South Korea
-
- Sejin Lee
- Department of Pharmacy and Yonsei Institute of Pharmaceutical Sciences Yonsei University Yeonsu-gu Incheon 21983 South Korea
-
- Hye Yun Kim
- Department of Pharmacy and Yonsei Institute of Pharmaceutical Sciences Yonsei University Yeonsu-gu Incheon 21983 South Korea
-
- Songmin Lee
- Department of Pharmacy and Yonsei Institute of Pharmaceutical Sciences Yonsei University Yeonsu-gu Incheon 21983 South Korea
-
- Jisu Shin
- Department of Pharmacy and Yonsei Institute of Pharmaceutical Sciences Yonsei University Yeonsu-gu Incheon 21983 South Korea
-
- Donghee Lee
- Department of Pharmacy and Yonsei Institute of Pharmaceutical Sciences Yonsei University Yeonsu-gu Incheon 21983 South Korea
-
- Kyeonghwan Kim
- Department of Pharmacy and Yonsei Institute of Pharmaceutical Sciences Yonsei University Yeonsu-gu Incheon 21983 South Korea
-
- InWook Park
- Department of Pharmacy and Yonsei Institute of Pharmaceutical Sciences Yonsei University Yeonsu-gu Incheon 21983 South Korea
-
- Soljee Yoon
- Department of Pharmacy and Yonsei Institute of Pharmaceutical Sciences Yonsei University Yeonsu-gu Incheon 21983 South Korea
-
- Jiyoon Kim
- Brain Science Institute Korea Institute of Science and Technology Seongbuk-gu Seoul 02792 South Korea
-
- Seong Jeong Park
- Amyloid Solution Bundang-gu Seongnam-si Gyeonggi-do 13486 South Korea
-
- Seong Muk Kim
- Amyloid Solution Bundang-gu Seongnam-si Gyeonggi-do 13486 South Korea
-
- Ko Eun Kim
- Amyloid Solution Bundang-gu Seongnam-si Gyeonggi-do 13486 South Korea
-
- Hye Ju Kim
- Amyloid Solution Bundang-gu Seongnam-si Gyeonggi-do 13486 South Korea
-
- Min‐Seok Oh
- Advanced Analysis and data Center Korea Institute of Science and Technology Seongbuk-gu Seoul 02792 South Korea
-
- Gwan‐Ho Lee
- Advanced Analysis and data Center Korea Institute of Science and Technology Seongbuk-gu Seoul 02792 South Korea
-
- Byung‐Yong Yu
- Advanced Analysis and data Center Korea Institute of Science and Technology Seongbuk-gu Seoul 02792 South Korea
-
- Priyadharshini Kannan
- Department of Biochemical Engineering Gangneung-Wonju National University Gangneung 25457 South Korea
-
- Keunwan Park
- Natural Product Informatics Research Center Korea Institute of Science and Technology Gangwon-do 25451 South Korea
-
- YoungSoo Kim
- Department of Pharmacy and Yonsei Institute of Pharmaceutical Sciences Yonsei University Yeonsu-gu Incheon 21983 South Korea
この論文をさがす
説明
<jats:title>Abstract</jats:title><jats:p>Amyloid‐β (Aβ) in the form of neurotoxic aggregates is regarded as the main pathological initiator and key therapeutic target of Alzheimer's disease. However, anti‐Aβ drug development has been impeded by the lack of a target needed for structure‐based drug design and low permeability of the blood–brain barrier (BBB). An attractive therapeutic strategy is the development of amyloid‐based anti‐Aβ peptidomimetics that exploit the self‐assembling nature of Aβ and penetrate the BBB. Herein, we designed a dimeric peptide drug candidate based on the N‐terminal fragment of Aβ, DAB, found to cross the BBB and solubilize Aβ oligomers and fibrils. Administration of DAB reduced amyloid burden in 5XFAD mice, and downregulated neuroinflammation and prevented memory impairment in the Y‐maze test. Peptide mapping assays and molecular docking studies were utilized to elucidate DAB‐Aβ interaction. To further understand the active regions of DAB, we assessed the dissociative activity of DAB with sequence modifications.</jats:p>
収録刊行物
-
- Angewandte Chemie International Edition
-
Angewandte Chemie International Edition 62 (7), 2023-01-12
Wiley